Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OTLK Outlook Therapeutics, Inc.

休市中 12-26 16:00:00 EST

1.82

-0.01

-0.55%

盘后1.86

+0.04+2.19%

19:59 EST

最高1.95	最低1.79	成交量454.16万
今开1.89	昨收1.83	日振幅9.02%
总市值1.17亿	流通市值8,878万	总股本6,411万
成交额845.09万	换手率9.31%	流通股本4,878万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OTLK","market":"US","secType":"STK","nameCN":"Outlook Therapeutics, Inc.","latestPrice":1.82,"timestamp":1766782800000,"preClose":1.83,"halted":0,"volume":4541616,"hourTrading":{"tag":"盘后","latestPrice":1.8599,"preClose":1.82,"latestTime":"19:59 EST","volume":62746,"amount":115597.6018,"timestamp":1766797185464},"delay":0,"floatShares":48780400,"shares":64114399,"eps":-1.501597,"marketStatus":"休市中","change":-0.01,"latestTime":"12-26 16:00:00 EST","open":1.89,"high":1.95,"low":1.785,"amount":8450866.471392,"amplitude":0.090164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.501597,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766998800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.83,"preHourTrading":{"tag":"盘前","latestPrice":1.88,"preClose":1.83,"latestTime":"09:29 EST","volume":88227,"amount":168779.0979792,"timestamp":1766759370087},"postHourTrading":{"tag":"盘后","latestPrice":1.8599,"preClose":1.82,"latestTime":"19:59 EST","volume":62746,"amount":115597.6018,"timestamp":1766797185464},"volumeRatio":0.8804002496188847,"impliedVol":3.7621,"impliedVolPercentile":0.864},"requestUrl":"/m/hq/s/OTLK","defaultTab":"news","newsList":[{"id":"1174726101","title":"Outlook Therapeutics Inc：Ons-5010如获批准，将以Lytenava品牌用于湿性年龄相关性黄斑变性治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1174726101","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174726101?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:31","pubTimestamp":1763040691,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics Inc：Ons-5010如获批准，将以Lytenava品牌用于湿性年龄相关性黄斑变性治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLK","BK4139"],"gpt_icon":0},{"id":"1137059470","title":"FDA拒绝批准眼部疾病药物后，Outlook Therapeutics, Inc.股价盘前暴跌60.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137059470","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137059470?lang=zh_cn&edition=full","pubTime":"2025-08-28 18:35","pubTimestamp":1756377317,"startTime":"0","endTime":"0","summary":"FDA拒绝批准眼部疾病药物后，Outlook Therapeutics, Inc.股价盘前暴跌60.4%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OTLK"],"gpt_icon":0},{"id":"1151455951","title":"Outlook Therapeutics：FDA建议为Ons-5010申请提交确认性疗效证据","url":"https://stock-news.laohu8.com/highlight/detail?id=1151455951","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151455951?lang=zh_cn&edition=full","pubTime":"2025-08-28 18:32","pubTimestamp":1756377134,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics表示，美国食品药品监督管理局(FDA)建议该公司提交确认性疗效证据，以支持其Ons-5010产品的申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLK","BK4139"],"gpt_icon":0},{"id":"1155673207","title":"Outlook Therapeutics就FDA审查Ons-5010/Lytenava™(Bevacizumab-Vikg)湿性AMD治疗药物提供监管进展更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1155673207","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155673207?lang=zh_cn&edition=full","pubTime":"2025-08-28 18:30","pubTimestamp":1756377034,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics就美国食品药品监督管理局审查其Ons-5010/Lytenava™(Bevacizumab-Vikg)湿性年龄相关性黄斑变性治疗药物的情况提供了监管进展更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLK","BK4139"],"gpt_icon":0},{"id":"2552487713","title":"Outlook Therapeutics, Inc.盘中异动 快速跳水5.39%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552487713?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:39","pubTimestamp":1752763158,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时39分，Outlook Therapeutics, Inc.股票出现异动，股价急速跳水5.39%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃，换手率分别为870.62%、380.58%、188.31%，振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为148.12%、81.11%、61.18%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223918a4515e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223918a4515e44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2518042662","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大跌5.34%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518042662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518042662?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:56","pubTimestamp":1741633004,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时56分，Outlook Therapeutics, Inc.股票出现异动，股价急速下跌5.34%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6148.90%、3854.04%、1014.79%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311025644a26a9d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311025644a26a9d94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2517698565","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大涨5.28%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517698565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517698565?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:19","pubTimestamp":1741119563,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时19分，Outlook Therapeutics, Inc.股票出现异动，股价急速上涨5.28%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041923a25f65a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041923a25f65a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2516688296","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516688296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516688296?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:02","pubTimestamp":1741032163,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时02分，Outlook Therapeutics, Inc.股票出现异动，股价大幅跳水5.00%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4576.31%、211.77%、182.41%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040243abe68edc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040243abe68edc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2514566375","title":"Outlook Therapeutics, Inc.盘中异动 早盘快速拉升5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514566375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514566375?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:53","pubTimestamp":1740754380,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时53分，Outlook Therapeutics, Inc.股票出现异动，股价急速上涨5.80%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225300abe0f06f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225300abe0f06f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2514045867","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大跌5.23%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514045867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514045867?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:28","pubTimestamp":1740511706,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时28分，Outlook Therapeutics, Inc.股票出现波动，股价急速跳水5.23%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032826abdcc28f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032826abdcc28f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OTLK"],"gpt_icon":0},{"id":"2513214988","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513214988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513214988?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:07","pubTimestamp":1740168426,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时07分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.43%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Moolec Science Sa C/Wts 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为316.92%、251.10%、138.24%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222040707a24ef57e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222040707a24ef57e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2512166707","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.35%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166707?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:01","pubTimestamp":1739890874,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时01分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.35%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230114abd3b5ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230114abd3b5ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2511257095","title":"Outlook Therapeutics, Inc.盘中异动 临近收盘快速上涨5.17%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511257095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511257095?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:50","pubTimestamp":1739479816,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时50分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升5.17%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Moleculin Biotech, Inc.、Dominari Holdings Inc.、Edesa Biotech, Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3288.28%、2317.46%、1269.38%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045016988475bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045016988475bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2510332620","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.33%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510332620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510332620?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:05","pubTimestamp":1739293558,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时05分，Outlook Therapeutics, Inc.股票出现异动，股价大幅下跌5.33%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.74%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3014.30%、1344.27%、439.69%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120105589881d747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120105589881d747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2510894173","title":"Outlook Therapeutics, Inc.盘中异动 快速下挫5.26%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510894173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510894173?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:04","pubTimestamp":1739217899,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时04分，Outlook Therapeutics, Inc.股票出现波动，股价急速下跌5.26%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110404599880b79d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110404599880b79d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2509786716","title":"Outlook Therapeutics, Inc.盘中异动 下午盘大幅下挫5.08%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509786716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509786716?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:28","pubTimestamp":1738873734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时28分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.08%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207042854987cc11b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207042854987cc11b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2509528298","title":"Outlook Therapeutics, Inc.盘中异动 急速下跌6.85%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509528298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509528298?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765902,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Outlook Therapeutics, Inc.股票出现异动，股价大幅跳水6.85%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为2635.51%、595.53%、583.64%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Eyepoint Pharmaceuticals, Inc.、Oragenics Inc.，振幅分别为16.82%、11.68%、9.75%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223142abc37d7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223142abc37d7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OTLK"],"gpt_icon":0},{"id":"2508246149","title":"Outlook Therapeutics, Inc.盘中异动 大幅下挫5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508246149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508246149?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593145,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Outlook Therapeutics, Inc.股票出现波动，股价急速下挫5.81%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为323.74%、236.31%、126.79%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Briacell Therapeutics Corp.，振幅分别为35.77%、33.33%、13.55%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032232259616fb7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032232259616fb7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2507969682","title":"Outlook Therapeutics, Inc.盘中异动 快速拉升7.43%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507969682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507969682?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:46","pubTimestamp":1738334803,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时46分，Outlook Therapeutics, Inc.股票出现波动，股价快速拉升7.43%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224643abbe3e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224643abbe3e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2506475301","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速下跌5.03%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506475301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506475301?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:50","pubTimestamp":1737993008,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时50分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.03%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Dogwood Therapeutics, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1916.85%、362.03%、213.54%，振幅较大的相关个股有Onconetix, Inc.、Dogwood Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为85.35%、75.00%、65.16%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272350089874bd36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272350089874bd36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.outlooktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0945},{"period":"1month","weight":0.0833},{"period":"3month","weight":0.8761},{"period":"6month","weight":0.1375},{"period":"1year","weight":0.0706},{"period":"ytd","weight":-0.037}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Outlook Therapeutics, Inc.于2010年1月5日在新泽西州注册成立。该公司是一家生物制药公司，在欧盟或欧盟、英国或英国率先获得ONS-5010/LYTENAVA（贝伐珠单抗-gamma）眼科制剂上市许可，用于治疗湿性年龄相关性黄斑变性，或湿性AMD。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.117155},{"month":2,"riseRate":0.444444,"avgChangeRate":0.160578},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.049534},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.10242},{"month":5,"riseRate":0.666667,"avgChangeRate":0.154179},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.046947},{"month":7,"riseRate":0.6,"avgChangeRate":0.042124},{"month":8,"riseRate":0.3,"avgChangeRate":-0.178581},{"month":9,"riseRate":0.5,"avgChangeRate":0.048784},{"month":10,"riseRate":0.5,"avgChangeRate":0.176993},{"month":11,"riseRate":0.2,"avgChangeRate":-0.102562},{"month":12,"riseRate":0.4,"avgChangeRate":-0.093741}],"exchange":"NASDAQ","name":"Outlook Therapeutics, Inc.","nameEN":"Outlook Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Outlook Therapeutics, Inc.,OTLK,Outlook Therapeutics, Inc.股票,Outlook Therapeutics, Inc.股票老虎,Outlook Therapeutics, Inc.股票老虎国际,Outlook Therapeutics, Inc.行情,Outlook Therapeutics, Inc.股票行情,Outlook Therapeutics, Inc.股价,Outlook Therapeutics, Inc.股市,Outlook Therapeutics, Inc.股票价格,Outlook Therapeutics, Inc.股票交易,Outlook Therapeutics, Inc.股票购买,Outlook Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}